Compare CNTB & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | PETS |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 61.6M |
| IPO Year | 2020 | 2003 |
| Metric | CNTB | PETS |
|---|---|---|
| Price | $2.75 | $2.40 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 1 |
| Target Price | ★ $8.50 | $3.20 |
| AVG Volume (30 Days) | ★ 112.6K | 86.6K |
| Earning Date | 03-31-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.22 | 18.92 |
| EPS | ★ N/A | N/A |
| Revenue | $26,033,000.00 | ★ $273,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24,617.69 | $2.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $1.57 |
| 52 Week High | $3.28 | $4.32 |
| Indicator | CNTB | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 31.73 |
| Support Level | $2.09 | $2.41 |
| Resistance Level | $2.89 | $2.93 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 55.96 | 16.65 |
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.